214 related articles for article (PubMed ID: 29330299)
1. Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity.
Graf L; Dick A; Sendker F; Barth E; Marz M; Daumke O; Kochs G
J Biol Chem; 2018 Mar; 293(9):3056-3072. PubMed ID: 29330299
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.
Dick A; Graf L; Olal D; von der Malsburg A; Gao S; Kochs G; Daumke O
J Biol Chem; 2015 May; 290(20):12779-92. PubMed ID: 25829498
[TBL] [Abstract][Full Text] [Related]
3. Influenza Virus Susceptibility of Wild-Derived CAST/EiJ Mice Results from Two Amino Acid Changes in the MX1 Restriction Factor.
Nürnberger C; Zimmermann V; Gerhardt M; Staeheli P
J Virol; 2016 Dec; 90(23):10682-10692. PubMed ID: 27654285
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus.
Patzina C; Haller O; Kochs G
J Biol Chem; 2014 Feb; 289(9):6020-7. PubMed ID: 24448803
[TBL] [Abstract][Full Text] [Related]
5. An evolutionarily conserved N-terminal leucine is essential for MX1 GTPase antiviral activity against different families of RNA viruses.
McKellar J; Arnaud-Arnould M; Chaloin L; Tauziet M; Arpin-André C; Pourcelot O; Blaise M; Moncorgé O; Goujon C
J Biol Chem; 2023 Jan; 299(1):102747. PubMed ID: 36436557
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
7. Mx proteins: GTPases involved in the interferon-induced antiviral state.
Pavlovic J; Schröder A; Blank A; Pitossi F; Staeheli P
Ciba Found Symp; 1993; 176():233-43; discussion 243-7. PubMed ID: 7507812
[TBL] [Abstract][Full Text] [Related]
8. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus.
Zürcher T; Pavlovic J; Staeheli P
J Virol; 1992 Aug; 66(8):5059-66. PubMed ID: 1321288
[TBL] [Abstract][Full Text] [Related]
10. Rare variant
Chen Y; Graf L; Chen T; Liao Q; Bai T; Petric PP; Zhu W; Yang L; Dong J; Lu J; Chen Y; Shen J; Haller O; Staeheli P; Kochs G; Wang D; Schwemmle M; Shu Y
Science; 2021 Aug; 373(6557):918-922. PubMed ID: 34413236
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus.
Nigg PE; Pavlovic J
J Biol Chem; 2015 Dec; 290(50):29893-906. PubMed ID: 26507657
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of oligomerization in the stalk region of dynamin-like MxA.
Gao S; von der Malsburg A; Paeschke S; Behlke J; Haller O; Kochs G; Daumke O
Nature; 2010 May; 465(7297):502-6. PubMed ID: 20428112
[TBL] [Abstract][Full Text] [Related]
13. Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.
Verhelst J; Spitaels J; Nürnberger C; De Vlieger D; Ysenbaert T; Staeheli P; Fiers W; Saelens X
J Virol; 2015 Nov; 89(21):10879-90. PubMed ID: 26292322
[TBL] [Abstract][Full Text] [Related]
14. Mx GTPases: dynamin-like antiviral machines of innate immunity.
Haller O; Staeheli P; Schwemmle M; Kochs G
Trends Microbiol; 2015 Mar; 23(3):154-63. PubMed ID: 25572883
[TBL] [Abstract][Full Text] [Related]
15. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
[TBL] [Abstract][Full Text] [Related]
16. Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity.
Haller O; Gao S; von der Malsburg A; Daumke O; Kochs G
J Biol Chem; 2010 Sep; 285(37):28419-24. PubMed ID: 20538602
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, GTP recognition mechanism and tissue-specific expression profiling of myxovirus resistance (Mx) protein in Labeo rohita (Hamilton) after Poly I:C induction.
Das BK; Roy P; Rout AK; Sahoo DR; Panda SP; Pattanaik S; Dehury B; Behera BK; Mishra SS
Sci Rep; 2019 Mar; 9(1):3956. PubMed ID: 30850653
[TBL] [Abstract][Full Text] [Related]
18. Eurasian Avian-Like Swine Influenza A Viruses Escape Human MxA Restriction through Distinct Mutations in Their Nucleoprotein.
Dornfeld D; Petric PP; Hassan E; Zell R; Schwemmle M
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355693
[TBL] [Abstract][Full Text] [Related]
19. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity.
Ponten A; Sick C; Weeber M; Haller O; Kochs G
J Virol; 1997 Apr; 71(4):2591-9. PubMed ID: 9060610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
